#China's #CorxelPharmaceuticals' latest round is further evidence of #biotech #investors' insatiable appetite for companies with #obesity programmes, with backers ploughing $287 million into its Series D.
Corxel's raises $287m for obesity drug, and other financings
Our latest biofinancing round-up sees big rounds for Corxel and Caldera, with Mendra, Think Bio, Exciva, Cytotheryx, and Infinitopes also raising cash.
buff.ly
January 23, 2026 at 1:00 PM
#China's #CorxelPharmaceuticals' latest round is further evidence of #biotech #investors' insatiable appetite for companies with #obesity programmes, with backers ploughing $287 million into its Series D.